288 related articles for article (PubMed ID: 27497264)
1. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
Ray JG; Ranganathan K; Chattopadhyay A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
[TBL] [Abstract][Full Text] [Related]
3. Oral submucous fibrosis: review on mechanisms of malignant transformation.
Ekanayaka RP; Tilakaratne WM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
Chattopadhyay A; Ray JG
J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
[TBL] [Abstract][Full Text] [Related]
5. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
[TBL] [Abstract][Full Text] [Related]
8. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.
Ranganathan K; Kavitha R; Sawant SS; Vaidya MM
J Oral Pathol Med; 2006 Jan; 35(1):25-32. PubMed ID: 16393250
[TBL] [Abstract][Full Text] [Related]
11. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications.
Xiao X; Hu Y; Li C; Shi L; Liu W
Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822
[TBL] [Abstract][Full Text] [Related]
12. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
[TBL] [Abstract][Full Text] [Related]
14. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
15. Identification of the pattern of copper as an etiological factor in oral submucous fibrosis: a cytological study.
Sharma A; Sahni P; Nayak MT; Singhvi A; Kumar R
J Exp Ther Oncol; 2014; 10(4):317-23. PubMed ID: 25509987
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.
Yang PY; Chen YT; Wang YH; Su NY; Yu HC; Chang YC
J Oral Pathol Med; 2017 Nov; 46(10):1040-1045. PubMed ID: 28295637
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
[TBL] [Abstract][Full Text] [Related]
18. Oral submucous fibrosis. The South African experience.
VanWyk CW
Indian J Dent Res; 1997; 8(2):39-45. PubMed ID: 9495135
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical biomarkers in oral submucous fibrosis: A scoping review.
Kavitha L; Ranganathan K; Shyam S; Fathima JHS; Umesh W; Warnakulasuriya S
J Oral Pathol Med; 2022 Aug; 51(7):594-602. PubMed ID: 35102645
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
Phulari RGS; Dave EJ
Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
